Why Meliora?
Female Breast Cancer stands as a significant global health hurdle, making up 11.7% of all cancer cases in 2020, with 2.3 million new cases. Its impact reaches beyond mortality, affecting societal and economic dimensions.
Prevention faces hurdles like awareness gaps, skills deficiencies, and socio-demographic inequities, contributing to avoidable cases. Disparities persist in rural areas and among individuals with lower education levels.
MELIORA, is a collaborative initiative addressing these challenges with innovative solutions. Using digital health technologies and lifestyle interventions, MELIORA aims to bridge existing gaps, offering cost-efficient, effective, and sustainable Breast Cancer prevention programs. The intervention, featuring personalised guidance, feedback, and information materials, will be delivered through healthcare professionals and digital tools, including the MELIORA intelligent Virtual Coach.
MELIORA: A JOINT MISSION
News and Events
Find out about the latest MELIORA related news and events.
Discussion at the Lithuanian Parliament highlights the importance of early detection and quality of life for women affected by breast cancer
On October 20, the Lithuanian Cancer Patient Coalition (POLA) marked Breast Cancer Awareness Month with a roundtable discussion at the Lithuanian Parliament, organized together with Member of Parliament Saulius Čaplinskas. The event, titled “Breast Cancer [...]
Driving innovation in breast cancer prevention: MELIORA partners meet in Stockholm
On 16–17 June 2025, MELIORA partners gathered in Stockholm, Sweden for the project’s second consortium meeting. Hosted at the Karolinska Institutet, the two-day meeting brought together researchers, clinicians, technologists, communication experts, and patient representatives [...]
INCLIVA and Hospital Clínico de Valencia hold a meeting to bring research closer to breast cancer patients and understand their concerns
This article was authored by INCLIVA Biomedical Research Institute The Breast Cancer Biology Research Group at the INCLIVA Biomedical Research Institute and the Breast Cancer Unit at the Hospital Clínico de Valencia have organised a [...]
